BIOTIE THERAPIES OYJ has a total of 16 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Finland, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, foods and drinks and measurement are Thanares GmbH, A1M PHARMA AB and MAEDA KAZUHISA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Finland | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Environmental technology | |
#6 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Natunen Jari | 7 |
#2 | Teneberg Susann | 5 |
#3 | Karlsson Karl-Anders | 5 |
#4 | Miller-Podraza Halina | 5 |
#5 | Helin Jari | 5 |
#6 | Pihlavisto Marjo | 4 |
#7 | Smith David | 4 |
#8 | Roche Niamh | 3 |
#9 | Johnson Mark | 3 |
#10 | Aangstroem Jonas | 3 |
Publication | Filing date | Title |
---|---|---|
FI20040270A0 | Hydrazino alcohol derivatives useful as inhibitors of copper containing amine oxidases | |
FI20040271A0 | Crystalline VAP-1 and its use | |
FI20031536A0 | High affinity ligands for influenza viruses and their production processes | |
FI20030977A0 | Bioidentifikaitonskonjugat | |
FI20030786A0 | New use of VAP-1 | |
FI20030564A0 | Substances that bind zoonotic Helicobacter species and their use | |
FI20030415A0 | Sulfoniamidijohdannaisia | |
FI20021772A0 | Novel carbohydrate compositions and process for their preparation | |
FI20020807A0 | Novel humanized anti-VAP-1 monoclonal antibodies | |
FI20002015A0 | Copper-containing amine oxidase inhibitors |